Homology Medicines (FIXX) Financials

$0.89

$-15.80 (-94.66%)

As on 25-Mar-2024 18:27EDT

Market cap

$3 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	1.16	3.21	33.97	2.70	1.67	3.68
Cost of Revenue	0.58	2.60	9.54	100.39	89.40	47.95
Gross Profit	0.58	0.61	24.43	-97.69	-87.73	3.68
Operating Expenses	92.68	136.49	129.92	132.97	111.61	65.25
Operating Profit (EBIT)	-92.10	-133.28	-95.95	-130.26	-109.94	-61.56
Other Income	--	134.48	0.19	1.57	6.03	4.35
Profit before Tax	-87.08	1.20	-95.76	-128.69	-103.92	-57.22
Provision for Tax	25.88	0.72	-0.19	-1.57	-6.03	4.35
Profit after Tax (Net Income)	-112.96	0.48	-95.58	-127.13	-97.89	-57.22
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	-5.01	-95.76	-128.69	-103.92	-55.58

Liabilities ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	72.99	177.98	169.65	196.00	258.51	194.72
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	221.55	27.92	24.84	45.08	39.69	38.94
Current Liabilities	11.57	22.58	17.23	22.66	12.37	25.43
Total Liabilities	306.12	228.47	211.72	263.74	310.57	259.09

Assets ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	222.21	47.46	19.81	44.17	43.99	37.41
Current Assets	83.91	181.02	191.91	219.56	266.58	221.69
Total Assets	306.12	228.47	211.72	263.74	310.57	259.09
Total Debt*	1.32	29.48	23.93	15.44	--	--
Net Current Assets	72.34	158.44	174.68	196.91	254.20	196.25

Cashflow ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	-96.23	-113.66	-109.75	-94.33	-91.36	-42.56
Cash Flow from Investing Activities	--	36.72	-50.79	204.90	-51.80	-121.79
Cash from Financing Activities	0.18	0.60	52.17	53.09	158.21	150.99
Net Cash Inflow / Outflow	--	-76.35	-108.37	163.66	15.06	-13.36

Financials Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-1.95	0.01	-1.67	-2.81	-2.17	-1.53
Cash EPS ($)	-1.93	0.03	-1.53	-2.63	-2.03	-1.50
Adjusted Book Value ($)	1.26	3.10	2.97	4.33	5.73	5.21
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-1.66	-1.98	-1.92	-2.09	-2.02	-1.14
Free Cash Flow per Share ($)	-1.66	-2.00	-1.96	-2.17	-2.51	-1.81

Profitability Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	-80.18	0.24	-47.20	-54.10	-43.20	-39.05
ROE (%)	-90.02	0.28	-52.28	-55.94	-43.20	-39.05
ROA (%)	-42.26	0.22	-40.21	-44.27	-34.37	-28.85
EBIT Margin (%)	-7,967.30	-4,154.64	-282.44	-4,820.98	-6,599.22	-1,671.12
Net Margin (%)	-9,771.71	0.35	-279.83	-2,976.47	-1,272.44	-712.25
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	-0.64	-0.91	11.57	0.62	-0.55	--
EBIT Growth (%)	30.90	-38.91	26.34	-18.48	-78.58	-107.58
Net Profit Growth (%)	-23,487.37	100.51	24.81	-29.87	-71.09	-90.77
EPS Growth (%)	-232.73	1.01	0.40	-0.30	-0.42	0.05
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	-0.31	149.96	-2.17	-4.02	-9.55	-14.61
Price / Book Value	0.48	0.41	1.23	2.61	3.62	4.29
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.50	0.28	-0.87	-2.52	-6.49	-10.31
Close Price ($)	5.47	11.34	32.76	101.61	186.30	201.24
High Price ($)	15.84	38.34	137.16	201.42	286.20	238.50
Low Price ($)	4.12	9.36	32.49	78.30	99.45	135.63
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	0.02	0.17	0.14	0.08	--	--
Short term debt to equity ratio	0.02	0.01	0.00	0.01	--	--
Current Ratio	7.25	8.02	11.14	9.69	21.54	8.72
Quick Ratio	--	--	--	9.69	21.54	--
Interest Coverage	--	-0.51	-518.64	-83.02	--	--

Operating Efficiency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	9.35	--	14.80	24.01	21.72
Asset Turnover	0.00	0.01	0.14	0.01	0.01	0.02
Receivable days	94.79	34.16	4.30	54.07	131.54	79.32
Inventory Days	--	--	0.00	0.00	0.00	--
Payable days	1,383.27	246.64	135.63	13.33	37.47	69.59
Cash Conversion Cycle	--	--	-131.33	40.74	94.08	--